Discontinued — last reported Q3 '23
Salesforce Interest Paid increased by 375.0% to $133.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.9%, from $87.00M to $133.00M. Over 4 years (FY 2022 to FY 2026), Interest Paid shows an upward trend with a 24.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.00M | $2.00M | $46.00M | $93.00M | $46.00M | $92.00M | $46.00M | $91.00M | $46.00M | $90.00M | $28.00M | $90.00M | $28.00M | $90.00M | $28.00M | $87.00M | $28.00M | $87.00M | $28.00M | $133.00M |
| QoQ Change | — | -95.7% | >999% | +102.2% | -50.5% | +100.0% | -50.0% | +97.8% | -49.5% | +95.7% | -68.9% | +221.4% | -68.9% | +221.4% | -68.9% | +210.7% | -67.8% | +210.7% | -67.8% | +375.0% |
| YoY Change | — | — | — | — | +0.0% | >999% | +0.0% | -2.2% | +0.0% | -2.2% | -39.1% | -1.1% | -39.1% | +0.0% | +0.0% | -3.3% | +0.0% | -3.3% | +0.0% | +52.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.